KEY MEMBERS
NeoImmuneTech, Inc. (NIT) is led by seasoned executives relentlessly pursuing the development of novel drug in immuno-oncology.
Se Hwan Yang, Ph.D. - President / Chief Executive Officer
Dr. Se Hwan Yang founded NeoImmuneTech in January 2014. Dr. Yang has created several intellectual-property protected inventions, including the hyFc® platform technology and drug candidate. Prior to his position at NIT, Dr. Yang was Genexine’s Head of Research Institute and Business division from 2007 to 2014 and has served as a BOD member of Genexine. He received his Ph.D. from Pohang University of Science and Technology and has over 20 years of experiences of research, product development and business in life sciences, including molecular biology, immunology and protein engineering.
Dr. Se Hwan Yang founded NeoImmuneTech in January 2014. Dr. Yang has created several intellectual-property protected inventions, including the hyFc® platform technology and drug candidate. Prior to his position at NIT, Dr. Yang was Genexine’s Head of Research Institute and Business division from 2007 to 2014 and has served as a BOD member of Genexine. He received his Ph.D. from Pohang University of Science and Technology and has over 20 years of experiences of research, product development and business in life sciences, including molecular biology, immunology and protein engineering.
KEY MEMBERS
Clinical Division
Byung Ha Lee
Ph.D.
Chief Scientific Officer
/ Head of Clinical Division
Hye Jeong
M.D.
Medical Director of Drug
Safety and Pharmacovigilance
Sara Ferrando Martinez
Ph.D.
Head of Clinical Sciences
Mary E. Muench-Holum
Head of Clinical Operations
Quality Assurance Division
Jiyoung Joo
Chief Quality Officer
/ Head of QA Division
Hee Yong Jeong
Executive Director
of CMC QA
Richard Sloma
Senior Director of
Clinical QA
CMC Division
Eun Jeong Bae
Senior Director
/ Head of CMC Division
Regulatory Affairs Division
Jin Hee Kang
Chief Regulatory Officer
/ Head of RA Division
Alicia Staz
RA Director
Eui Sok Jung
RA Director
Research Institute
Donghoon Choi
Ph.D.
Chief Technology Officer
/ Head of Research Institute
S&P Division
Daniel Rho
Director / Director of
Strategy & Planning
Hyun Jee Kim
Executive Director
Finance Division
Tae Woo Kim
CPA
Chief Financial Officer
/ Head of Finance Division
Investor Relations Division
Hayoung Lee
Chief Investor Relations Officer
/ Head of IR Division
Management Division
Gene Namgoong
Chief Operating Officer
/ Head of Management Division
Dana Wyche
IT Director
Soon Phil Lee
Senior Director
/ Management